Acomplia Information

Acomplia (Rimonabant)

Although clinical studies on Acomplia Rimonabant have shown that smoking habits have improved and craving for nicotine has considerably reduced in patients, Acomplia Rimonabant has not been licensed as an anti-smoking drug in UK. It has been approved only to be used in anti-obesity treatment. So we strongly advise you to seek a face to face consultation with your doctor prior to starting Acomplia Rimonabant treatment as it is a prescription medication. Your family doctor or certified medical practitioner knows the best for you and we recommend that you follow their advice.

Acomplia slimming pills work as appetite suppressant. Acomplia contains Rimonabant as the active ingredient which acts as a cannabinoid type I (CB1) receptor and works in the brain to produce feelings of fullness even by eating less food. Acomplia has succeeded in entering the European markets with the European Union's nod to market it as an anti-obesity drug. Acomplia has been clinically proven to reduce weight .Two years of successful clinical trials have finally paved the way for people looking at anti-obesity treatments to buy Acomplia Rimonabant as a means to control obesity. However, you need to maintain healthy diet and exercise while on treatment with Acomplia.

Frequently Asked Questions

What is Acomplia?

Acomplia Rimonabant works directly on the urge or craving to eat more. This is accomplished by working on the endocannabinoid system, a system affecting energy balance, glucose and lipid metabolism and body weight. Acomplia works by blocking certain receptors in the brain that will result in the patient experiencing the feeling of being full thus wanting to eat less than normal. Intake of Acomplia in conjunction with a calorie reduced but healthy diet and exercise significantly helps obese patients achieve weight loss.

TOP

What are the benefits of Acomplia Rimonabant?

Along with effective weight loss, Acomplia discourages bad habits like smoking. It is also an anti-smoking pill and improves HDL (good cholesterol) and triglyceride levels. This way Acomplia Rimonabant benefits diabetes and heart conditions as well. Usual recommended dosage of Rimonabant is 20mg per day based on the advice of your doctor depending on your health.

TOP

What are the side effects of Acomplia Rimonabant?

No pill is without side-effects. Acomplia has a few minor side effects which are very temporary and transient. These include nausea, dizziness, diarrhea, vomiting, hypoglycaemia, anxiety and mood swings.

Acomplia is a promising new drug with a wide range of possibilities of application to various diseases and health problems.

TOP

What are the precautions to be taken?

Acomplia clinical trials have revealed certain depressive disorders or mood changes. Up to 10% depressive disorders where reported in patients taking Acomplia. Also suicidal thoughts were reported in 1% of patients taking Acomplia Rimonabant.

Acomplia Precautions

• If you are under the treatment of ongoing major depressive illness and are also taking antidepressants for it, don’t take Acomplia.
• Acomplia Rimonabant should not be taken by patients who have or had in past, suicidal thoughts or depressive disorder. If however it is found that the benefits far outweigh the risks.
• Acomplia is not recommended in patients with uncontrolled psychiatric illness excluding depression.
• Always consider the risk of taking Acomplia yourself and with your caretakers or relatives before you take it.
• If at anytime you experience any symptoms of depression, stop taking Rimonabant immediately.

TOP

Clinical Tests of Acomplia Rimonabant

A third of the patients given 20mg of Acomplia Rimonabant lost more than 10 percent of their initial body weight over a period of two years. Around 62 percent of patients given 20mg Acomplia daily lost at least 5 percent of body weight. Waist circumference at two years was reduced by 3.1 inches (8 cm) in the 20mg Acomplia group, by 1.9 inches (4.9 cm) in the 5mg group. From the tests, 20mg dosage was more effective than the lower dose.

TOP